Company profile: Labcorp Drug Development
1.1 - Company Overview
Company description
- Provider of global contract research and drug development services, delivering early- and late-stage support including drug discovery studies, preclinical and clinical pharmacology, clinical trial execution with patient recruitment and data analysis, biomarker services, oncology research (cell line assays, tumor models), biopharma laboratory services with antibody-drug conjugate capabilities, and cell and gene therapy development.
Products and services
- Clinical Trial Services: Delivers global-scale development and execution of clinical trials, orchestrating patient recruitment and data analysis across studies
- Preclinical Studies: Executes nonclinical programs, applying regulatory expertise to support drug candidate development and early phase development
- Drug Discovery Services: Architects early-stage discovery studies to fast-track candidate selection with optimized study design and data interpretation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Labcorp Drug Development
Julius Clinical
HQ: The Netherlands
Website
- Description: Provider of clinical trial services offering full-service or functional support across CNS diseases (ALS, dementia, Parkinson’s, epilepsy, hearing loss), cardio-metabolic and renal, and infectious diseases & vaccines. Leverages Brain Clinical and scientific site networks to optimize protocols and streamline trials. Provides CRO from early to post-registration, real-world data, and SMO with large-scale recruitment and site support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Julius Clinical company profile →
Almac
HQ: United Kingdom
Website
- Description: Provider of contract development and manufacturing services to pharmaceutical and biotech companies globally, including R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, and IXRS technology. Offers genomic services, clinical trial assays, companion diagnostics, PD biomarker testing, CDx manufacturing, and the claraT software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Almac company profile →
Health Decisions
HQ: United States
Website
- Description: Provider of full-service contract research organization services specializing in clinical studies of therapeutics for women’s health and diagnostics across all therapeutic areas; focused on women’s health for over 28 years with more than 100 trials in women-only indications such as contraception, serving forward-looking biopharma and medical device companies and supporting modernization of clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Decisions company profile →
Celerion
HQ: United States
Website
- Description: Provider of early clinical research and Applied Translational Medicine, translating research discoveries into knowledge of drug action in humans to support early development decisions. Services include bioanalytical sciences for small and large molecules; clinical development (safety, PK/PD); data management and biometrics; global drug development (regulatory, project management); EDC; and eTMF via secure, DIA-formatted portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celerion company profile →
Remus Pharmaceuticals
HQ: United States
Website
- Description: Provider of sterile liquid injectables and oral solid forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remus Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Labcorp Drug Development
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Labcorp Drug Development
2.2 - Growth funds investing in similar companies to Labcorp Drug Development
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Labcorp Drug Development
4.2 - Public trading comparable groups for Labcorp Drug Development
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →